Mo1191 - Bevacizumab as Treatment of Bleeding in Patients with Hereditary Haemorrhagic Telangiectasia (HHT)

Authors :: Anette Drøhse Kjeldsen
Jens Kjeldsen
Tine Rosenberg
Annette Dam Fialla
Source :: Gastroenterology. 154:S-701
Publication Year :: 2018
Publisher :: Elsevier BV, 2018.

Subjects :: 0301 basic medicine
medicine.medical_specialty
Hepatology
Bevacizumab
business.industry
Gastroenterology
Hereditary haemorrhagic telangiectasia (HHT)
medicine.disease
03 medical and health sciences
030104 developmental biology
0302 clinical medicine
Internal medicine
medicine
030211 gastroenterology & hepatology
In patient
business
medicine.drug

Full Text Access

Tools